Recently added

Precemtabart tocentecan, an anti-CEACAM5 antibody–drug conjugate, in metastatic colorectal cancer: a phase 1 trial

Raghav, Kanwal; Pallis, Athanasios; Kopetz, Scott; Boni, Valentina; Kato, Ken; Vieito , Maria (Nature Portfolio, 2025-10)

Standardised TruAI Automated Quantification of Intracellular Neuromelanin Granules in Human Brain Tissue Sections

Cuadros Arasa, Thais; Chatterton, Zac; Burke, Amy; Ansari Mahabadian, Anahid; Compte, Joan; Filimontseva, Anastasia; Vila, Miquel (Wiley, 2025-08)

Identification of cellular factors associated with inflammation and neurodegeneration in multiple sclerosis

Rodero-Romero, Alexander; Fernández Velasco, José Ignacio; Sainz-Amo, Raquel; Alvarez-Lafuente, Roberto; Montalban, Xavier; Monreal, Enric; Comabella Lopez, Manuel (Frontiers Media, 2025-08-07)

Randomised trial of trastuzumab deruxtecan and biology-driven selection of neoadjuvant treatment for HER2-positive breast cancer: a study protocol of ARIADNE

Naume, Bjørn; wildiers, hans; Sonke, Gabe; Karakatsanis, Andreas; Matikas, Alexios; DIECI, MARIA VITTORIA; Villacampa Javierre, Guillermo (BMJ, 2025-08)

Metabolic dysfunction-associated steatohepatitis reduces hepatic H2S-producing enzymes altering persulfidome composition

SHEN, TZU-KENG; Vignane, Thibaut; Gilglioni, Eduardo Hideo; Traini, Leonardo; Kalaitsidou, Elisavet; Conan, Pierre; Herranz Alzueta, Jose Mari (Elsevier, 2025-10)

Scientia. Dipòsit d'Informació Digital del Departament de Salut

Institut Català de la Salut - ICS: Recent submissions

Precemtabart tocentecan, an anti-CEACAM5 antibody–drug conjugate, in metastatic colorectal cancer: a phase 1 trial

Standardised TruAI Automated Quantification of Intracellular Neuromelanin Granules in Human Brain Tissue Sections

Identification of cellular factors associated with inflammation and neurodegeneration in multiple sclerosis

Randomised trial of trastuzumab deruxtecan and biology-driven selection of neoadjuvant treatment for HER2-positive breast cancer: a study protocol of ARIADNE

Metabolic dysfunction-associated steatohepatitis reduces hepatic H2S-producing enzymes altering persulfidome composition

Scientia. Dipòsit d'Informació Digital del Departament de Salut

Institut Català de la Salut - ICS: Recent submissions

Precemtabart tocentecan, an anti-CEACAM5 antibody–drug conjugate, in metastatic colorectal cancer: a phase 1 trial ﻿

Standardised TruAI Automated Quantification of Intracellular Neuromelanin Granules in Human Brain Tissue Sections ﻿

Identification of cellular factors associated with inflammation and neurodegeneration in multiple sclerosis ﻿

Randomised trial of trastuzumab deruxtecan and biology-driven selection of neoadjuvant treatment for HER2-positive breast cancer: a study protocol of ARIADNE ﻿

Metabolic dysfunction-associated steatohepatitis reduces hepatic H2S-producing enzymes altering persulfidome composition ﻿

Precemtabart tocentecan, an anti-CEACAM5 antibody–drug conjugate, in metastatic colorectal cancer: a phase 1 trial

Standardised TruAI Automated Quantification of Intracellular Neuromelanin Granules in Human Brain Tissue Sections

Identification of cellular factors associated with inflammation and neurodegeneration in multiple sclerosis

Randomised trial of trastuzumab deruxtecan and biology-driven selection of neoadjuvant treatment for HER2-positive breast cancer: a study protocol of ARIADNE

Metabolic dysfunction-associated steatohepatitis reduces hepatic H2S-producing enzymes altering persulfidome composition